Xiamen, China The main office of represented VC is situated in the Xiamen. The company was established in Asia in China.
The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Dyee Capital, startups are often financed by RMB Funds, Legend Capital, China Growth Capital. The meaningful sponsors for the fund in investment in the same round are Lilly Asia Ventures, Capital Today, Xiamen C&D Corporation. In the next rounds fund is usually obtained by Silicon Valley Bank, Qualcomm Ventures, Legend Capital.
Among the most popular portfolio startups of the fund, we may highlight FineEx, Hebaodan, Borns Robot. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Among the most popular fund investment industries, there are E-Commerce, Health Care. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund.
This organization was formed by Dezhen Zhu.
The common things for fund are deals in the range of 10 - 50 millions dollars. The important activity for fund was in 2018. The fund is generally included in 2-6 deals every year. The real fund results show that this VC is 20 percentage points more often commits exit comparing to other companies.
Related Funds
| Fund Name | Location |
| Adolfsen Group | - |
| Ajuntament de Barcelona | - |
| Birmingham City Council | Birmingham, England, United Kingdom |
| Bulldog Innovation Group LLC | Connecticut, New Haven, United States |
| Cassidy Asset Management | - |
| CH Investment Partners | Dallas, Texas, United States |
| Computime Equity Ventures | Missouri, Saint Louis, United States |
| Encourage Technologies | Hokkaido Prefecture, Japan, Sapporo |
| Foregrowth | Canada, Ontario, Toronto |
| Invested Development | Boston, Massachusetts, United States |
| Kakao Mobility | Kyonggi-do, Seongnam, South Korea |
| Kowloon Nights | China, Hong Kong, Hong Kong Island |
| Nassau Capital | New Jersey, Princeton, United States |
| Stylebread | Hokkaido, Hokkaido Prefecture, Japan |
| Sunrise Securities | New York, New York, United States |
| Techinvest | Austria, Vienna |
| Teradyne | Massachusetts, North Reading, United States |
| ViaNet Ventures | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Weikaier Pharmaceutical Technology | $69M | 02 Jan 2024 | Nanjing, Jiangsu, China | ||
Huayuan Regenerative Medicine | 20 Nov 2023 | Shenzhen, Guangdong, China | |||
Jinfang Pharmaceutical | $75M | 09 Mar 2023 | Shanghai, Shanghai, China | ||
BridGene Biosciences | $38M | 27 Jul 2022 | Sunnyvale, California, United States | ||
Degron Therapeutics | $22M | 09 Jun 2022 | Shanghai, Shanghai, China | ||
Microclear | 23 May 2022 | Gusu District, Jiangsu, China | |||
Cloudbreak Therapeutics | $130M | 01 Jan 2022 | Irvine, California, United States | ||
GenFleet Therapeutics | $77M | 31 Dec 2021 | Shanghai, China | ||
Zhimeng Biopharma | $54M | 08 Nov 2021 | Zhangdian District, Shandong, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Weikaier Pharmaceutical Technology | $69M | 02 Jan 2024 | Nanjing, Jiangsu, China | ||
Huayuan Regenerative Medicine | 20 Nov 2023 | Shenzhen, Guangdong, China | |||
Jinfang Pharmaceutical | $75M | 09 Mar 2023 | Shanghai, Shanghai, China | ||
BridGene Biosciences | $38M | 27 Jul 2022 | Sunnyvale, California, United States | ||
Degron Therapeutics | $22M | 09 Jun 2022 | Shanghai, Shanghai, China | ||
Microclear | 23 May 2022 | Gusu District, Jiangsu, China | |||
Cloudbreak Therapeutics | $130M | 01 Jan 2022 | Irvine, California, United States | ||
GenFleet Therapeutics | $77M | 31 Dec 2021 | Shanghai, China | ||
Zhimeng Biopharma | $54M | 08 Nov 2021 | Zhangdian District, Shandong, China |
